题为《心血管疾病的分子药理学与干预》特刊的社论
Editorial for the Special Issue Titled "Molecular Pharmacology and Interventions in Cardiovascular Disease".
作者信息
Zabielska-Kaczorowska Magdalena
机构信息
Department of Physiology, Medical University of Gdansk, 80-211 Gdansk, Poland.
出版信息
Int J Mol Sci. 2025 Sep 3;26(17):8582. doi: 10.3390/ijms26178582.
Abstract
Cardiovascular diseases (CVDs) include coronary artery disease, hypertension, and various cardiac disorders, among other conditions that impact the heart and vascular system [...].
摘要
心血管疾病（CVDs）包括冠状动脉疾病、高血压以及各种心脏疾病，以及其他影响心脏和血管系统的病症[……]。
相似文献
1
Editorial for the Special Issue Titled "Molecular Pharmacology and Interventions in Cardiovascular Disease".题为《心血管疾病的分子药理学与干预》特刊的社论
Int J Mol Sci. 2025 Sep 3;26(17):8582. doi: 10.3390/ijms26178582.
2
Cellular senescence and senotherapeutics in cardiovascular diseases.心血管疾病中的细胞衰老与衰老治疗学
Adv Pharmacol. 2025;104:313-349. doi: 10.1016/bs.apha.2025.01.019. Epub 2025 Feb 24.
3
Effectiveness of eHealth Interventions in Improving Medication Adherence Among Patients With Cardiovascular Disease: Systematic Review and Meta-Analysis.电子健康干预措施在提高心血管疾病患者药物依从性方面的有效性：系统评价和荟萃分析。
J Med Internet Res. 2024 Jul 15;26:e58013. doi: 10.2196/58013.
4
Molecular mechanisms of aberrant fatty acids metabolism in driving cardiovascular diseases: key regulatory targets and dietary interventions.异常脂肪酸代谢在引发心血管疾病中的分子机制：关键调控靶点与饮食干预
Food Funct. 2025 Jul 28;16(15):5961-5993. doi: 10.1039/d5fo01237f.
5
Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease.手机短信用于心血管疾病二级预防中的药物依从性。
Cochrane Database Syst Rev. 2024 Mar 27;3(3):CD011851. doi: 10.1002/14651858.CD011851.pub3.
6
Survivin in cardiovascular diseases and its therapeutic potential.存活素在心血管疾病中的作用及其治疗潜力。
Vascul Pharmacol. 2025 Jun;159:107475. doi: 10.1016/j.vph.2025.107475. Epub 2025 Feb 25.
7
The adverse effect of mood swings on the risk of cardiovascular diseases: Evidence from Mendelian randomization analysis.情绪波动对心血管疾病风险的不良影响：来自孟德尔随机化分析的证据。
Medicine (Baltimore). 2024 Dec 20;103(51):e41003. doi: 10.1097/MD.0000000000041003.
8
SIRT3 as a potential biomarker and therapeutic target for cardiovascular diseases: a meta-analysis of clinical studies.SIRT3作为心血管疾病的潜在生物标志物和治疗靶点：临床研究的荟萃分析
Future Cardiol. 2025 Aug;21(10):779-788. doi: 10.1080/14796678.2025.2527535. Epub 2025 Jul 4.
9
Role of impaired mitochondrial dynamics and mitophagy in cardiovascular diseases: Possible therapeutic approaches.线粒体动力学受损和线粒体自噬在心血管疾病中的作用：可能的治疗方法。
Life Sci. 2025 Jul 30;379:123890. doi: 10.1016/j.lfs.2025.123890.
10
Mediterranean Diet for Primary and Secondary Prevention of Cardiovascular Disease and Mortality: An Updated Systematic Review.地中海饮食对心血管疾病和死亡率的一级和二级预防作用：一项更新的系统性综述。
Nutrients. 2023 Jul 28;15(15):3356. doi: 10.3390/nu15153356.
本文引用的文献
1
IL-6R Signaling Is Associated with PAD4 and Neutrophil Extracellular Trap Formation in Patients with STEMI.IL-6R信号传导与ST段抬高型心肌梗死患者的PAD4及中性粒细胞胞外诱捕网形成相关。
Int J Mol Sci. 2025 Jun 2;26(11):5348. doi: 10.3390/ijms26115348.
2
Catestatin in Cardiovascular Diseases.心血管疾病中的降钙素抑制肽
Int J Mol Sci. 2025 Mar 7;26(6):2417. doi: 10.3390/ijms26062417.
3
Prolonged Extracorporeal Circulation Leads to Inflammation and Higher Expression of Mediators of Vascular Permeability Through Activation of STAT3 Signaling Pathway in Macrophages.长时间的体外循环会通过激活巨噬细胞中的 STAT3 信号通路导致炎症和血管通透性介质表达升高。
Int J Mol Sci. 2024 Nov 19;25(22):12398. doi: 10.3390/ijms252212398.
4
Synthetic Flavonoid 3,7-Dihydroxy-Isoflav-3-Ene (DHIF) Reduces In-Stent Restenosis in an Atherosclerotic Watanabe Heritable Hyperlipidemic Rabbit Stent Model.合成类黄酮 3,7-二羟基异黄酮-3-烯（DHIF）可减少动脉粥样硬化兔 Watanabe 遗传性高脂血症模型中的支架内再狭窄。
Int J Mol Sci. 2024 Oct 27;25(21):11530. doi: 10.3390/ijms252111530.
5
The Interaction of Vasopressin with Hormones of the Hypothalamo-Pituitary-Adrenal Axis: The Significance for Therapeutic Strategies in Cardiovascular and Metabolic Diseases.血管升压素与下丘脑-垂体-肾上腺轴激素的相互作用：对心血管和代谢疾病治疗策略的意义。
Int J Mol Sci. 2024 Jul 5;25(13):7394. doi: 10.3390/ijms25137394.
6
A Novel Strategy for the Treatment of Aneurysms: Inhibition of MMP-9 Activity through the Delivery of TIMP-1 Encoding Synthetic mRNA into Arteries.一种治疗动脉瘤的新策略：通过将 TIMP-1 编码的合成 mRNA 递送至动脉来抑制 MMP-9 活性。
Int J Mol Sci. 2024 Jun 15;25(12):6599. doi: 10.3390/ijms25126599.
7
Does Cell-Type-Specific Silencing of Monoamine Oxidase B Interfere with the Development of Right Ventricle (RV) Hypertrophy or Right Ventricle Failure in Pulmonary Hypertension?单胺氧化酶 B 的细胞类型特异性沉默是否会干扰肺动脉高压中的右心室（RV）肥大或 RV 衰竭的发展？
Int J Mol Sci. 2024 Jun 5;25(11):6212. doi: 10.3390/ijms25116212.
8
Genetic Mutations and Mitochondrial Redox Signaling as Modulating Factors in Hypertrophic Cardiomyopathy: A Scoping Review.遗传突变与线粒体氧化还原信号在肥厚型心肌病中的调节作用：系统评价
Int J Mol Sci. 2024 May 28;25(11):5855. doi: 10.3390/ijms25115855.
9
Therapies for Cirrhotic Cardiomyopathy: Current Perspectives and Future Possibilities.肝硬化性心肌病的治疗方法：现状与未来可能。
Int J Mol Sci. 2024 May 28;25(11):5849. doi: 10.3390/ijms25115849.
10
Investigation of Strategies to Block Downstream Effectors of AT1R-Mediated Signalling to Prevent Aneurysm Formation in Marfan Syndrome.探讨阻断 AT1R 介导的信号下游效应子以预防马凡综合征中动脉瘤形成的策略。
Int J Mol Sci. 2024 May 4;25(9):5025. doi: 10.3390/ijms25095025.
Zotero 插件